| 1 |
31123968 | Cilostazol add-on therapy for celecoxib synergistically inhibits proinflammatory cytokines by activating IL-10 and SOCS3 in the synovial fibroblasts of patients with rheumatoid arthritis. | 2019 Dec |
2 |
| 2 |
28850024 | Cilostazol inhibits the expression of hnRNP A2/B1 and cytokines in human dermal microvascular endothelial cells. | 2017 Nov-Dec |
1 |
| 3 |
26345215 | Cilostazol inhibits plasmacytoid dendritic cell activation and antigen presentation. | 2015 Jul |
2 |
| 4 |
23072581 | Suppression of PU.1-linked TLR4 expression by cilostazol with decrease of cytokine production in macrophages from patients with rheumatoid arthritis. | 2013 Mar |
1 |
| 5 |
21153029 | Cilostazol reduces the progression of carotid intima-media thickness without increasing the risk of bleeding in patients with acute coronary syndrome during a 2-year follow-up. | 2011 Sep |
1 |
| 6 |
21660147 | HO-1 Induced by Cilostazol Protects Against TNF-α-associated Cytotoxicity via a PPAR-γ-dependent Pathway in Human Endothelial Cells. | 2011 Apr |
5 |
| 7 |
20131233 | Cilostazol enhances apoptosis of synovial cells from rheumatoid arthritis patients with inhibition of cytokine formation via Nrf2-linked heme oxygenase 1 induction. | 2010 Mar |
2 |
| 8 |
18703532 | Cilostazol inhibits cytokine-induced nuclear factor-kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells. | 2009 Jan 1 |
4 |
| 9 |
19967051 | Synergistic efficacy of concurrent treatment with cilostazol and probucol on the suppression of reactive oxygen species and inflammatory markers in cultured human coronary artery endothelial cells. | 2008 Aug |
3 |
| 10 |
16472148 | Cilostazol: therapeutic potential against focal cerebral ischemic damage. | 2006 |
3 |
| 11 |
16547169 | Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via mediation of cAMP-dependent protein kinase-mediated maxi-K channel activation. | 2006 Jun |
1 |
| 12 |
16822680 | Protection from apoptotic cell death by cilostazol, phosphodiesterase type III inhibitor, via cAMP-dependent protein kinase activation. | 2006 Oct |
2 |
| 13 |
15734902 | Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor-null mice fed high cholesterol. | 2005 May |
2 |
| 14 |
14569058 | Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells. | 2004 Jan |
5 |
| 15 |
14967724 | Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. | 2004 Mar 2 |
1 |
| 16 |
12807996 | Cilostazol prevents tumor necrosis factor-alpha-induced cell death by suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and activation of Akt/cyclic AMP response element-binding protein phosphorylation. | 2003 Sep |
6 |
| 17 |
11805237 | Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells. | 2002 Feb |
1 |
| 18 |
11500182 | Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-kappaB binding to its recognition sequence. | 2001 Sep |
4 |